Regeneron Pharmaceuticals (NASDAQ:REGN) Shareholders Have Earned a 15% CAGR Over the Last Five Years

Yahoo FinanceNov 23 22:00

Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby

Seeking AlphaNov 23 21:26

Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters

Seeking AlphaNov 23 04:00

Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)

Earnings Call TranscriptsNov 20 05:09

High Alpha Stocks That Are Rated 'Overweight' – MS

Seeking AlphaNov 20 03:40

Regeneron Pharmaceuticals's Options: A Look at What the Big Money Is Thinking

BenzingaNov 20 01:15